A carregar...

MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes

Myelodysplastic syndrome (MDS) is a heterogeneous group of hematological malignancies with considerably variable prognoses and curable only with hematopoietic cell transplantation (HCT). Few studies comparing MDS HCT outcomes between sibling and umbilical cord blood (UCB) donors exist. Using the Uni...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bone Marrow Transplant
Main Authors: Pourhassan, H, DeFor, T, Trottier, B, Dolan, M, Brunstein, C, Bejanyan, N, Ustun, C, Warlick, E D
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5382091/
https://ncbi.nlm.nih.gov/pubmed/27941767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2016.303
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!